Cover of Why Can Essential Medicines Remain in Short Supply Even When Manufacturers Have Production Capacity?

Analysis · Business & Industry

Why Can Essential Medicines Remain in Short Supply Even When Manufacturers Have Production Capacity?

ORV-110 · ORV-BBI-011 · BBI-011
Coming SoonNot available for purchase or download

About this publication

Pharmaceutical manufacturing capacity does not always translate into medicines that can be released and supplied to the market.

Using documented manufacturing-quality developments, industry shortage evidence, and US FDA regulatory information, this analysis examines how production capacity, quality testing, batch release requirements, and pharmaceutical market conditions can affect the availability of essential medicines, particularly sterile injectable products.

Publication
Analysis
Primary domain
Business & Industry
Producer
ORVESTRA
Department
Business Architecture
Rights
P’Toh
Framework
DGCP™
License
DGCP | MMFARM-POL-2025

CID: bafkreihbq3zdexcfvsjkyoylvjgeiphdeopt6576lncmm72mijkswhwvu4

← Back to Knowledge Library